Fishawack buys Brighton comms agency
July 2, 2014Medical Communications Brighton, Facilitate, comms, fishawack
Medical communications firm Fishawack has acquired the UK, Brighton-based agency Facilitate as part of its
 ongoing purchasing strategy. Facilitate will …
PD-1 cancer race heats up as Merck takes lead
July 2, 2014Research and Development, Sales and Marketing ASCO, Cancer, Merck, melanoma, mk3475, oncology, pembrolizumab
Merck’s oncology drug pembrolizumab has taken a big step towards becoming Europe’s first PD-1 cancer treatment as the EMA accepts …
Reuters chief executive joins Pfizer board
July 2, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, james smith, reuters
Pfizer has appointed the chief executive of information and media giant Thomson Reuters to its board of directors. James Smith …
Doctors who miss cancer to be named and shamed
July 1, 2014Sales and Marketing Cancer, GPs, Hunt, NHS, UK, doctors, oncology
In a new government initiative doctors who consistently fail to diagnose signs of cancer could be publically named on an …
BASF and chemical giants building new MDI plant
July 1, 2014Manufacturing and Production BASF, China, Huntsman, SINOPEC, Shanghai, Shanghai Chlor-Alkali, Shanghai Hua Yi, mdi
BASF, Huntsman, Shanghai Hua Yi, Shanghai Chlor-Alkali and SINOPEC are teaming up to construct a new MDI plant in China. …
Astellas names Americas head
July 1, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Tatjana Dragovic, americas
Astellas has appointed Tatjana Dragovic as its VP and regional compliance officer for the firm’s Americas region. In this role …
Government gets £74m rebate from pharma
June 30, 2014Sales and Marketing ABPI, Hunt, NHS, PPRS, VBP, emms, pricing
The UK government has received a £74 million refund from the pharma industry after it was deemed to have spent …
FDA ‘yes’ to inhaled insulin
June 30, 2014Manufacturing and Production, Sales and Marketing Afrezza, FDA, Mannkind, diabetes, insulin human
The FDA has approved the first ‘ultra-rapid-acting’ mealtime insulin therapy available in the US, to improve glycemic control in both …
GSK China sex tape ‘sent to Witty’
June 30, 2014Medical Communications, Research and Development, Sales and Marketing China, GSK, Mark Reilly, Witty, corruption, sex tape
GlaxoSmithKline was scrambling to defend itself over the weekend as new details emerged concerning the extent of its suspected corruption …
CHMP approves six drugs including daclatasvir
June 30, 2014Sales and Marketing BMS, CHMP, HCV, Plavix, daclatasvir, daklinza, ge
A key advisory committee for the European Medicines Agency has given its approval to six new drugs at its latest …
Quantum Pharmaceutical adds head of commercial
June 30, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brown, quantum pharma
UK medicines supplier and manufacturing firm Quantum Pharmaceutical has expanded its team with the appointment of a new head of …
Value tops the agenda at ASCO cancer conference
June 30, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ASCO, Cancer, chicago, mccafferty, oncology
The annual American Society of Clinical Oncology (ASCO) meeting has long been one of the most important events on the …
NICE U-turn on cancer drug despite price increase
June 27, 2014Sales and Marketing Cancer, Glivec, NHS, Novartis, gists
UK pricing watchdog NICE has performed a U-turn on Glivec (imatinib) by issuing new draft guidance recommending the drug, despite …
FDA rejects olaparib
June 27, 2014Sales and Marketing AstraZeneca, Cancer, FDA, PARP, adp, olaparib
AstraZeneca has been dealt a blow by a key advisory committee to the US Food and Drug Administration, which has …
Ranbaxy’s Diovan copycat approved in US
June 27, 2014Manufacturing and Production, Sales and Marketing Diovan, FDA, Novartis, Ranbaxy, blood pressure, sun pharmaceuticals, valsartan
Ranbaxy has won approval for its copycat form of Novartis’ blockbuster blood pressure drug Diovan, as the Swiss firm finally …
BMS expands data transparency
June 27, 2014Medical Communications, Sales and Marketing BMS, best electronic cigarettes, csr, dcri, transparency
Bristol-Myers Squibb is to expand access to its clinical trial data – but researchers’ requests will have to be approved …
Biotec names commercial director
June 27, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biotec, martin lamb
Clinical trials services firm Biotec Services International has appointed Martin Lamb to the position of commercial director. Lamb will lead …
NICE recommends tenth diabetes drug
June 26, 2014Sales and Marketing Janssen, NHS, diabetes, invokana, type 2
In final guidance NICE has recommended Janssen’s Invokana as a treatment to help lower blood sugar levels in people with …
FDA warns GSK plant
June 26, 2014Manufacturing and Production, Sales and Marketing FDA, GSK, Quebec, flu, flulaval, vaccines
GlaxoSmithKline’s Canadian operation has incurred the displeasure of the US Food and Drug Administration for irregularities in its production of …
Onyx Health launches women’s health blog
June 26, 2014Medical Communications A Snapshot of Women’s Health, Onyx, onyx health, women's blog
Healthcare agency Onyx Health has launched its own blog site and online community dedicated to women’s health. In what the …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
